1-2 of 2
Anna Ringler
Close
Sort by
Journal Articles

Next-Generation Functional Drug Screening for Patients with Aggressive Hematologic Malignancies

Philipp Bernhard Staber, MD PhD, Berend Snijder, PhD, Gregory Ian Vladimer, PhD, Nikolaus Krall, PhD, Katsuhiro Miura, MD, Ann-Sofie Schmolke, Christoph Kornauth, MD, Oscar Lopez de la Fuente, BSc, Hye-Soo Choi, Emiel van der Kouwe, Lukas Kazianka, MD, Johannes Bigenzahn1, MD PhD, Gregor Hoermann, MD, Nicole Prutsch, Olaf Merkel, PhD, Anna Ringler, Georg Jeryczynski, MD, Marius Mayerhoefer, MD, Ingrid Simonitsch-Klupp, MD, Franz X Felberbauer, MD, Leonhard Muellauer, MD PhD, Gerald W Prager, MD, Belgin Korkmaz, MD, Lukas Kenner, MD, Wolfgang R. Sperr, MD, Robert Kralovics, PhD, Heinz Gisslinger, Peter Valent, MD, Stefan Kubicek, PhD, Ulrich Jaeger, MD, Giulio Superti-Furga, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 855.
https://doi.org/10.1182/blood.V130.Suppl_1.855.855
Published: 2017
Journal Articles

Integrated ATAC-Seq and Chemosensitivity Profiling Identifies Rational Drug Combinations in Ibrutinib-Treated CLL Patients

Gregory Ian Vladimer, PhD, Christian Schmidl, PhD, Andre Renderio, MS, Susanne Schnabl, MS, Tea Pemovska, PhD, Berend Snijder, PhD, Thomas Krausgruber, PhD, Nikolaus Krall, PhD, Mohammad Araghi, Rainer Hubmann, Anna Ringler, Dita Demirtas, Oscar Lopez de la Fuente, BSc, Martin Hilgrath, Cathrin Skrabs, MD, Edit Anna Porpaczy, MD, Michaela Gruber, MD PhD, Gregor Hoermann, MD, Stefan Kubicek, PhD, Philipp Bernhard Staber, MD PhD, Medhat M. Shehata, MD, Giulio Superti-Furga, PhD, Christoph Bock, PhD, Ulrich Jaeger, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 800.
https://doi.org/10.1182/blood.V130.Suppl_1.800.800
Published: 2017